LABORATORY AND RADIOLOGICAL
FINDINGS IN HYPERPARATHYROIDISM
Hyperparathyroidism
• Hyperparathyroidism is a common cause of
hypercalcemia
• Prevalence of 1-4 cases per 1000 persons
• Most common in 7th decade and women(74%)
• Caused by hypersecretion of PTH usually by:
1. Single parathyroid adenoma(80%)
2. Hyperplasia of 2 or more parathyroid
glands(20%)
3. Carcinoma(≤1)
• Familial in 10% of cases
• Hyperplasia may arise in MEN types 1, 2A, 2B
• MEN1 has multiglandular hyperparathyroidism
as initial manifestation and ultimately occurs in
90%od affected individuals
• MEN2 has less frequent occurrence and is
milder
• Familial hyperparathyroidism can also occur in
hyperparathroidism-jaw tumor syndrome
• Rare autosomal dominant trait in which there is
association with ossifying fibromas of mandible,
maxilla and renal lesions
• Hyperparathyroidism results in excessive
excretion of calcium and phosphate by
kidneys
• PTH stimulates renal tubular reabsorption of
calcium; however in hyperparathyroidism causes
hypercalcemia and an increase in calcium in the
glomerular filtrate that overwhelms tubular
reabsorption capacity, resulting in hypercalciuria
• 5% of renal calculi are associated with this
• Excessive PTH can cause cortical
demineralization that is evident at wrist and
pelvis
• Chronic state can cause diffuse demineraliztion,
pathological fractures and cystic bone lesions;
osteitis fibrosa cystica
• In chronic renal disease hyperphosphatemia
and decreased renal production of 1,25-
dihydroxycholecalciferol initially produce a
decrease in ionized calcium
• Parathyroid glands are stimulated(secondary)
and may enlarge becoming
autonomous(tertiary)
• Renal disease here is called renal
osteodystrophy
• Parathyroid hyperplasia in uremia can result in
high serum PTH that lead to uremic vascular
calcification
• Hypercalcemia often occurs after kidney
transplant
• Parathyroid carcinoma is rare cause
• More common in patients with serum calcium
≥14mcg/dL
• 50% of parathyroid carcinoma are palpable
Clinical findings
• Mostly asymptomatic or mild symptoms
• Adenomas are small and deeply located, almost
never palpable
• Symptomatic patients have problems:
“Bones, stones, abdominal groans, psychic moans
with fatigue overtones”
Skeletal manifestations
• Loss of cortical bone
• Gain of trabecular bone
• Low bone density; particularly in wrist
• Asymptomatic vertebral fractures; post
menopausal women more prone
• Bone pain
• Arthralgia
• Brown tumors
• Cysts of jaw
Hypercalcemia manifestations
CNS
• Depression
• Constipation
• Bone and joint pain
• Paresthesia
• Muscular weakness
• Diminished deep tendon reflexes
• Malaise
• Fatigue
• Intellectual weariness
• Disorientation
Hypercalcemia manifestations
CVS
• Prolonged P-R interval
• Shortened Q-T interval
• Sensitivity to arrhythmic effects of digitalis
• Bradyarrhythmias
• Heart block
• Asystole
Hypercalcemia manifestations
Renal
• Polyuria
• Polydipsia
• Nephrogenic diabetes insipidus
• Calcium nephrolithiasis
Hypercalcemia manifestations
GI
• Anorexia
• Abdominal pain
• Weight loss
• Constipation
• Constipation
• Pancreatitis
MISC
• Pruritis
• Precipitation of Ca in cornea; band keratopathy
• Precipitation in extravascular tissue and arteries
causing small vessel thrombosis and skin necrosis
Laboratory findings
• Hypercalcemia with serum adjusted total
calcium ≥10.5 mg/dL
Adjusted total calcium=measured serum
calcium in mg/dL +[0.8x(4-patient’s serum
albumin in g/dL)]
• Serum ionized calcium in hyperproteinemic
states and hyperparathyroidism is >5.4mg/dL
• Low serum phosphate <2.5mg/dL due to loss in
urine
• In secondary renal disease serum phosphate is high
• Alkaline phosphatase is elevated if bone
disease present
• Plasma chloride and uric acid levels elevated
• Vitamin D deficiency
• Low serum 25-OH vitamin D levels <20mcg/L
aggravate bone manifestation
• Elevated serum level of intact PTH confirm
diagnosis (normal 10-65ng/L)
• 24hour urine for calcium and creatinine done to
screen for familial benign hypocalciuric
hypercalcemia; Ca <50mg/24hours
• Patients with low bone density and elevated PTH
but normal serum Ca must be evaluated for
causes of secondary hyperparathyroidism
• In absence of secondary hyperparthyroisim but
raised PTH and normal serum Ca patients are
said to have normocalcemic
hyperparathyroidism
Imaging
• Preoperative sestamibi-iodine subtraction scanning
• Involve injecting a small amount of special radioactive
material into a vein and taking an X-ray image of the
chest, neck, and head
• Accuracy rate of about 80 to 95%
• Neck ultrasound can locate parathyroid adenoma
• Adenomas appear as well-defined hypoechoic lesions
with potential cystic or necrotic areas.
• Ultrasonography offers the advantage of depicting
potential concomitant thyroid disease, present in 40%
of patients
• Helps in limiting the invasiveness in surgery
• CT and MRI of neck are helpful for ectopic
parathyroid glands
• CT scanning of kidneys to determine calcium
containing stones
• Bone density measurement by dual energy x-
ray absorptiometry(DXA) to see the bone loss
• DXA of lumbar spine, pelvis and distal radius
• X-rays to show bone demineralization;
subperiosteal resorption; radial aspects of fingers
• About 30-50% of the bone density must be lost to
show changes on radiographs.
• Loss of lamina dura of teeth
• Mottling of skull; salt and pepper appearance
• Pathological fractures
• Articular cartilage calcification
• In patients with renal osteodystrophy ectopic
calcifications around joints or soft tissue
• Radiographic changes show osteopenia, osteitis
fibrosa, osteosclerosis
• Osteosclerosis of vertebral bodies; rugger jersey
spine
Brown tumors
• Brown tumors are well-circumscribed lytic
lesions of bone that represent the osteoclastic
resorption of a confluent area of bone with
fibrous replacement.
• The lesions may be single or multiple, with
expansion of overlying bone, usually occur in
cortical bone.
• Common sites include the mandible, clavicle,
ribs, pelvis, and femur.
Distal femur shows scalloped defects along
the inner margin of the cortex, which
denote endosteal resorption.
Humerus- osseous expansion and
lucency of the proximal humerus.
Radiograph of the mid femoral diaphysis -
eccentric (arrowheads) and central
positions (arrow) of the lesions.
Management
• IV fluids
• Bisphosphonates; pamidronate, zoledronic acid
• Vitamin D and vitamin D analogs; calcitriol,
paricalcitrol, doxercalciferol
• Cinacalcet; calcimimetic agent
THANK YOU

laboratory and radiological findings in hyperparathyroidism

  • 1.
  • 2.
    Hyperparathyroidism • Hyperparathyroidism isa common cause of hypercalcemia • Prevalence of 1-4 cases per 1000 persons • Most common in 7th decade and women(74%) • Caused by hypersecretion of PTH usually by: 1. Single parathyroid adenoma(80%) 2. Hyperplasia of 2 or more parathyroid glands(20%) 3. Carcinoma(≤1)
  • 3.
    • Familial in10% of cases • Hyperplasia may arise in MEN types 1, 2A, 2B • MEN1 has multiglandular hyperparathyroidism as initial manifestation and ultimately occurs in 90%od affected individuals • MEN2 has less frequent occurrence and is milder • Familial hyperparathyroidism can also occur in hyperparathroidism-jaw tumor syndrome • Rare autosomal dominant trait in which there is association with ossifying fibromas of mandible, maxilla and renal lesions
  • 4.
    • Hyperparathyroidism resultsin excessive excretion of calcium and phosphate by kidneys • PTH stimulates renal tubular reabsorption of calcium; however in hyperparathyroidism causes hypercalcemia and an increase in calcium in the glomerular filtrate that overwhelms tubular reabsorption capacity, resulting in hypercalciuria • 5% of renal calculi are associated with this • Excessive PTH can cause cortical demineralization that is evident at wrist and pelvis • Chronic state can cause diffuse demineraliztion, pathological fractures and cystic bone lesions; osteitis fibrosa cystica
  • 5.
    • In chronicrenal disease hyperphosphatemia and decreased renal production of 1,25- dihydroxycholecalciferol initially produce a decrease in ionized calcium • Parathyroid glands are stimulated(secondary) and may enlarge becoming autonomous(tertiary) • Renal disease here is called renal osteodystrophy • Parathyroid hyperplasia in uremia can result in high serum PTH that lead to uremic vascular calcification • Hypercalcemia often occurs after kidney transplant
  • 6.
    • Parathyroid carcinomais rare cause • More common in patients with serum calcium ≥14mcg/dL • 50% of parathyroid carcinoma are palpable
  • 7.
    Clinical findings • Mostlyasymptomatic or mild symptoms • Adenomas are small and deeply located, almost never palpable • Symptomatic patients have problems: “Bones, stones, abdominal groans, psychic moans with fatigue overtones”
  • 8.
    Skeletal manifestations • Lossof cortical bone • Gain of trabecular bone • Low bone density; particularly in wrist • Asymptomatic vertebral fractures; post menopausal women more prone • Bone pain • Arthralgia • Brown tumors • Cysts of jaw
  • 9.
    Hypercalcemia manifestations CNS • Depression •Constipation • Bone and joint pain • Paresthesia • Muscular weakness • Diminished deep tendon reflexes • Malaise • Fatigue • Intellectual weariness • Disorientation
  • 10.
    Hypercalcemia manifestations CVS • ProlongedP-R interval • Shortened Q-T interval • Sensitivity to arrhythmic effects of digitalis • Bradyarrhythmias • Heart block • Asystole
  • 11.
    Hypercalcemia manifestations Renal • Polyuria •Polydipsia • Nephrogenic diabetes insipidus • Calcium nephrolithiasis
  • 12.
    Hypercalcemia manifestations GI • Anorexia •Abdominal pain • Weight loss • Constipation • Constipation • Pancreatitis MISC • Pruritis • Precipitation of Ca in cornea; band keratopathy • Precipitation in extravascular tissue and arteries causing small vessel thrombosis and skin necrosis
  • 13.
    Laboratory findings • Hypercalcemiawith serum adjusted total calcium ≥10.5 mg/dL Adjusted total calcium=measured serum calcium in mg/dL +[0.8x(4-patient’s serum albumin in g/dL)] • Serum ionized calcium in hyperproteinemic states and hyperparathyroidism is >5.4mg/dL
  • 14.
    • Low serumphosphate <2.5mg/dL due to loss in urine • In secondary renal disease serum phosphate is high • Alkaline phosphatase is elevated if bone disease present • Plasma chloride and uric acid levels elevated • Vitamin D deficiency • Low serum 25-OH vitamin D levels <20mcg/L aggravate bone manifestation • Elevated serum level of intact PTH confirm diagnosis (normal 10-65ng/L) • 24hour urine for calcium and creatinine done to screen for familial benign hypocalciuric hypercalcemia; Ca <50mg/24hours
  • 15.
    • Patients withlow bone density and elevated PTH but normal serum Ca must be evaluated for causes of secondary hyperparathyroidism • In absence of secondary hyperparthyroisim but raised PTH and normal serum Ca patients are said to have normocalcemic hyperparathyroidism
  • 16.
    Imaging • Preoperative sestamibi-iodinesubtraction scanning • Involve injecting a small amount of special radioactive material into a vein and taking an X-ray image of the chest, neck, and head • Accuracy rate of about 80 to 95% • Neck ultrasound can locate parathyroid adenoma • Adenomas appear as well-defined hypoechoic lesions with potential cystic or necrotic areas. • Ultrasonography offers the advantage of depicting potential concomitant thyroid disease, present in 40% of patients • Helps in limiting the invasiveness in surgery
  • 17.
    • CT andMRI of neck are helpful for ectopic parathyroid glands • CT scanning of kidneys to determine calcium containing stones • Bone density measurement by dual energy x- ray absorptiometry(DXA) to see the bone loss • DXA of lumbar spine, pelvis and distal radius
  • 18.
    • X-rays toshow bone demineralization; subperiosteal resorption; radial aspects of fingers • About 30-50% of the bone density must be lost to show changes on radiographs. • Loss of lamina dura of teeth • Mottling of skull; salt and pepper appearance • Pathological fractures • Articular cartilage calcification • In patients with renal osteodystrophy ectopic calcifications around joints or soft tissue • Radiographic changes show osteopenia, osteitis fibrosa, osteosclerosis • Osteosclerosis of vertebral bodies; rugger jersey spine
  • 23.
    Brown tumors • Browntumors are well-circumscribed lytic lesions of bone that represent the osteoclastic resorption of a confluent area of bone with fibrous replacement. • The lesions may be single or multiple, with expansion of overlying bone, usually occur in cortical bone. • Common sites include the mandible, clavicle, ribs, pelvis, and femur.
  • 28.
    Distal femur showsscalloped defects along the inner margin of the cortex, which denote endosteal resorption.
  • 29.
    Humerus- osseous expansionand lucency of the proximal humerus. Radiograph of the mid femoral diaphysis - eccentric (arrowheads) and central positions (arrow) of the lesions.
  • 31.
    Management • IV fluids •Bisphosphonates; pamidronate, zoledronic acid • Vitamin D and vitamin D analogs; calcitriol, paricalcitrol, doxercalciferol • Cinacalcet; calcimimetic agent
  • 32.